Safety, tolerability and efficacy of indacaterol, a novel once-daily β-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial

Jutta Beier (1) , Pascal Chanez (2) , J.-B. Jean-Benoit Martinot , A.J.M. Schreurs , R. Ružena Tkáčová (3) , Weibin Bao , Damon Jack (4) , Mark Higgins (4)

1 insaf Respiratory Research Institute
2 HCTLab - Human Computer Technology Laboratory
3 Department of Pneumology and Tuberculosis
4 Novartis Horsham Research Centre

Mots clés: Medicine

Jutta Beier, Pascal Chanez, J.-B. Jean-Benoit Martinot, A.J.M. Schreurs, R. Ružena Tkáčová, et al.. Safety, tolerability and efficacy of indacaterol, a novel once-daily β-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial. Pulmonary Pharmacology & Therapeutics, 2007, 20 (6), pp.740. ⟨10.1016/j.pupt.2006.09.001⟩. ⟨hal-00499139⟩